Shea TC - Search Results

1

Effectiveness of an algorithm-based approach to the utilization of plerixafor in patients undergoing chemotherapy-based stem cell mobilization.

Chow E, Rao KV, Wood WA, Covington D, Armistead PM, Coghill J, Serody JS, Gabriel DA, Jamieson KJ, Park YA, Raval JS, Shea TC. Chow E, et al. Among authors: shea tc. Biol Blood Marrow Transplant. 2014 Jul;20(7):1064-8. doi: 10.1016/j.bbmt.2014.03.023. Epub 2014 Apr 3. Biol Blood Marrow Transplant. 2014. PMID: 24704385 Free article.

2

A clinical and pharmacokinetic study of high-dose carboplatin, paclitaxel, granulocyte colony-stimulating factor, and peripheral blood stem cells in patients with unresectable or metastatic cancer.

Shea T, Graham M, Bernard S, Steagall A, Wiley J, Serody J, Brecher M, Bentley S, Johnston C, Vaisman A, et al. Shea T, et al. Semin Oncol. 1995 Oct;22(5 Suppl 12):80-5. Semin Oncol. 1995. PMID: 7481867 Clinical Trial.

3

Mobilization of peripheral blood progenitor cells with paclitaxel-based chemotherapy.

Shea TC. Shea TC. Semin Oncol. 1997 Feb;24(1 Suppl 2):S2-105-S2-107. Semin Oncol. 1997. PMID: 9045326 Review.

4

Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients.

Bentley SA, Brecher ME, Powell E, Serody JS, Wiley JM, Shea TC. Bentley SA, et al. Among authors: shea tc. Bone Marrow Transplant. 1997 Mar;19(6):557-63. doi: 10.1038/sj.bmt.1700717. Bone Marrow Transplant. 1997. PMID: 9085735

5

A method for the production of CD4+ chronic myelogenous leukemia-specific allogeneic T lymphocytes.

Serody JS, Brecher ME, Dent G, Bentley SA, Frelinger JA, Shea TC. Serody JS, et al. Among authors: shea tc. Cancer Res. 1997 Apr 15;57(8):1547-53. Cancer Res. 1997. PMID: 9108458

6

Prevention of infections in bone marrow transplant recipients.

Serody JS, Shea TC. Serody JS, et al. Among authors: shea tc. Infect Dis Clin North Am. 1997 Jun;11(2):459-77. doi: 10.1016/s0891-5520(05)70365-2. Infect Dis Clin North Am. 1997. PMID: 9187956 Review.

7

Murine T lymphocytes incapable of producing macrophage inhibitory protein-1 are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrier.

Serody JS, Cook DN, Kirby SL, Reap E, Shea TC, Frelinger JA. Serody JS, et al. Among authors: shea tc. Blood. 1999 Jan 1;93(1):43-50. Blood. 1999. PMID: 9864144 Free article.

8

Introduction: current issues in high-dose chemotherapy and stem cell support.

Shea TC. Shea TC. Bone Marrow Transplant. 1999 May;23 Suppl 2:S1-5. doi: 10.1038/sj.bmt.1701667. Bone Marrow Transplant. 1999. PMID: 10335870 Review.

9

CD34+ selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4 degrees C does not affect outcome.

Lazarus HM, Pecora AL, Shea TC, Koç ON, White JM, Gabriel DA, Cooper BW, Gerson SL, Krieger M, Sing AP. Lazarus HM, et al. Among authors: shea tc. Bone Marrow Transplant. 2000 Mar;25(5):559-66. doi: 10.1038/sj.bmt.1702175. Bone Marrow Transplant. 2000. PMID: 10713636 Clinical Trial.

10

Comparison of granulocyte colony-stimulating factor (G-CSF)--mobilized peripheral blood progenitor cells and G-CSF--stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation.

Serody JS, Sparks SD, Lin Y, Capel EJ, Bigelow SH, Kirby SL, Gabriel DA, Wiley JM, Brecher ME, Schell MJ, Folds J, Shea TC. Serody JS, et al. Among authors: shea tc. Biol Blood Marrow Transplant. 2000;6(4A):434-40. doi: 10.1016/s1083-8791(00)70035-8. Biol Blood Marrow Transplant. 2000. PMID: 10975512 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters